Chinese medicine for the treatment of SARS

Added March 31, 2020

Citation: Leung, PC. The efficacy of Chinese medicine for SARS: a review of Chinese publications after the crisis. American Journal of Chinese Medicine 2007; 35(4): 575-81

What is this? Like COVID-19, severe acute respiratory syndrome (SARS) is an acute respiratory disease caused by a coronavirus. Chinese medicine was used to treat patients with these earlier coronaviruses and might be considered as a treatment for COVID-19.

In this review, the author searched for research into the use of Chinese medicine for SARS. There is no information on any restrictions they applied in their search. The article was published in 2007 but the date of the search is not reported. The author identified 20 publications that they judged to be of high enough quality to summarize in the review.

What works: Nothing noted.

What doesn’t work: Nothing noted.

What’s uncertain: Although some research suggested benefits from the use of Chinese medicine for patients with SARS, the low quality of the available research means that the effects are uncertain.

 

Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.

Share